Back
Ovid Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Buy
63
OVID
Ovid Therapeutics
Last Price:
1.15
Seasonality Move:
-0.69%
Sell
44
LLY
Eli Lilly and
Last Price:
786.07
Seasonality Move:
3.42%
Buy
63
Ovid Therapeutics (OVID)
is a Buy
Is Ovid Therapeutics a Buy, Sell or Hold?
- The current Ovid Therapeutics [OVID] share price is $1.23. The Score for OVID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- OVID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $811.81. The Score for LLY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OVID Stock Price Chart
What is Ovid Therapeutics's stock price today?
-
The Ovid Therapeutics share price today is $1.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OVID is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $811.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
OVID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 52 | Buy |
Chaikin Money Flow: | 168484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.14 - 1.26) | Buy |
Bollinger Bands (100): | (0.92 - 1.22) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -25.16 | Sell |
Relative Strength Index (14 RSI): | 36.87 | Sell |
Chaikin Money Flow: | -2859668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (819.56 - 917.84) | Sell |
Bollinger Bands (100): | (842.18 - 940.38) | Sell |
OVID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.27 | Sell |
20-day SMA: | 1.22 | Buy |
50-day SMA: | 1.16 | Buy |
200-day SMA: | 2.11 | Sell |
8-day EMA: | 1.26 | Sell |
20-day EMA: | 1.22 | Buy |
50-day EMA: | 1.2 | Buy |
200-day EMA: | 1.85 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 810.09 | Buy |
20-day SMA: | 855.61 | Sell |
50-day SMA: | 888.81 | Sell |
200-day SMA: | 832.49 | Sell |
8-day EMA: | 820.9 | Sell |
20-day EMA: | 845.38 | Sell |
50-day EMA: | 872.5 | Sell |
200-day EMA: | 815.64 | Sell |
Ovid Therapeutics Earnings Growth & OVID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.24 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.90 per share, and an increase next year of $9.45 per share.
Ovid Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |